Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 added; Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.3 were removed.SummaryDifference0.2%

- Check9 days agoChange DetectedAdded Melanoma as a related topic and a MedlinePlus Genetics link; updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior notices for funding/operating status (Revision: v3.4.1).SummaryDifference0.4%

- Check44 days agoChange DetectedAdded a site-wide funding notice and updated the site version to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedAdded a glossary toggle and new metadata entries including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check59 days agoChange DetectedThe Melanoma and MedlinePlus Genetics related topics were removed from the page's related topics section, and this does not affect core study details or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.